Current Cancer Centers Using the ChemoID Assay

Recently Concluded Randomized Clinical Trials

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

LINK: clinicaltrials.gov/ct2/show/NCT03949283?cond=chemoid&rank=3

  • University of Cincinnati Cancer Center, Cincinnati, OH
  • Stephenson Cancer Center, University of Oklahoma, OK
  • Allegheny Health Network, Pittsburgh, PA
  • Edwards Cancer Center, Huntington, WV
  • Louisiana State University Medical Center, New Orleans
  • Charleston Area Medical Center, Charleston, WV
  • Kaiser Permanente, Los Angeles, California
  • Indiana University, Indianapolis, Indiana
  • Miami Cancer Institute, Miami, Florida+

Standard chemotherapy versus chemotherapy chosen by cancer stem cell chemosensitivity testing in the management of patients with recurrent Glioblastoma Multiforme (GBM).

LINK: clinicaltrials.gov/ct2/show/NCT03632135?cond=chemoid&rank=2

  • Allegheny Health Network, Pittsburgh, PA
  • Thomas Jefferson Hospital, Philadelphia
  • Penn State University Cancer Center, Hershey, PA
  • University of Cincinnati Brain Center, Cincinnati, OH
  • Charleston Area Medical Center, Charleston, WV
  • University of Toledo Medical Center, Toledo, OH
  • University of Mississippi Cancer Center, Jackson, MS
  • University of Maine, Scarborough, ME
  • Providence Cancer Center Oncology, Portland, Oregon
  • St. Luke’s University Health Network, Bethlehem, PA
  • Louisiana State University, New Orleans, LA
  • Kaiser Permanente, Los Angeles, CA
  • University of Southern California, Los Angeles, CA